Table 3 Data and information extraction schedule
Subject | Content |
|---|---|
Publication information | First author and correspondence author, e-mail, publish year, country, corporate sponsorship, percentage of authors from sponsoring company |
Participant | Recruitment source, sample size, age, gender, human race, diagnostic criteria, stage of AD, family history, inclusion and exclusion criteria |
Intervention | Drug name, based hypothesis, administration, dosage and usage, frequency of the treatment and the treatment course |
Control | Placebo, administration, dosage and usage, frequency of the treatment and the treatment course |
Outcome | Outcome measurements and each assessment time point, cognitive or biomarker endpoints, adverse events, and the detailed data |
Study design | Study duration, treatment and follow-up course, study sites, the application of randomization and blinding, description about statistical analysis, sample size calculation |
Other information | Attendance rate, reasons for withdrawing, combined treatment of AD |